Skip to content
thestock.space

On 6 Nov 2026, Paras Healthcare was priced at ₹734.55, or 84.0× trailing earnings, against an industry P/E of 47.7×. Sales grew 20% a year over 3 years, with ROCE of 14% and ROE of 13%. Debt is 3.21× equity. It is a small-cap company with a market cap of ₹7,946 Cr; the shares fell 0.1% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹774.00
Day high
₹774.00
Day low
₹728.20
Prev. close
₹774.20
Volume
4.1 L

Health check

3 fair · 3 to check
  • ReturnsIn line

    −0.1% over a year, better than 3 of 7 peers.

  • Price tagPricier

    P/E 84.0 vs industry 47.7.

  • GrowthSteady

    Sales +20.5% a year over 3 years.

  • ProfitabilityAverage

    ROCE 14.1% vs peer median 11.9%.

  • Balance sheetStretched

    Debt 3.21× equity, interest covered 2.8×.

  • Red flags3 to check

    Debt is 3.21× equity.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹7,946 Cr

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹1,708 Cr · profit ₹95 Cr
Market cap
₹7,946 Cr
Small cap
P/E
84.0
Industry 47.7
Price to book
18.78
Peers 8.06
Dividend yield
0.00%
ROE
13.0%
Peers 12.8%
ROCE
14.1%
Peers 11.9%
Debt to equity
3.21
Debt ₹1,429 Cr
EPS (TTM)
₹8.74
Face value ₹1
OPM (TTM)
38.5%
Net margin 5.5%
Sales growth
+27.7%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
4.65
EV/EBITDA 11.9

Strengths and risks

Strengths

  • Quarterly sales up 27.7% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Debt is 3.21× equity.
  • P/E of 84.0 against an industry P/E of 47.7.
  • Interest coverage of only 2.8×.

Derived automatically from reported figures. Not a recommendation.

About Paras Healthcare

Paras Healthcare Limited provides tertiary and quaternary healthcare services. The company provides cardiac sciences, neurosciences, oncology sciences, gastro sciences, orthopedics and sports injury, and renal sciences services. It offers services, such as cardio thoracic vascular surgery and cardiology; medical, radiation, surgical, and hemato oncology, as well as nuclear medicine and bone marrow transplant; and neuroscience, neuro intervention,…

Headquarters
Gurugram
Sector
Healthcare
ISIN
INE661T01029
Website
parashospitals.com

Price range

52 weeks

₹706.00₹794.40

Today

₹728.20₹774.00
Avg volume (3M)
19.1 L
1-year return
minus 0.1%
From 52-week high
minus 7.5%

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
PARASHLTHParas Healthcare734.55minus 5.12%–84.018.78–22.3%39.5%––0.00%minus 0.1%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Jun 26
368470
307364
61.7106
16.8%22.6%
4.96.8
27.630
32.535.1
−0.60.1
5.848.1
117.5%−3.2%
−149.7
-0.094.59

Sep 25, Dec 25, Mar 26 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+20.5%
ROE
13.0%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
9171,1291,2931,604
–+23.0%+14.6%+24.0%
8321,0071,1541,285
85122139318
9.3%10.8%10.8%19.9%
53.116.413.916.8
46.664.887.6115
65.580.7116144
−53.114.1−0−0.5
−27.16.6−5076
−58.2%331.2%−15.9%42.3%
−42.8−15.3−5843.8
-3.95-1.42-5.364.05

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3.79.89.810.1
26.4329271385
7569241,2321,394
507215298282
1,2931,4781,8102,071
8791,0251,2151,243
10444.64838.3
–00.10.1
23.115.537.261.2
287393510729
1,2931,4781,8102,071

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
43.792.586.2164
−126−194−147−239
97.59482.885.9
14.9−7.621.810
−113−198−137−169
−69.2−105−50.5−5.9

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company.

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you